Finance

Lists
DGX:NYSE
Quest Diagnostics Inc
USD 233,33
+0,97%
(+2,24) 1D
USD 233,33
0,00% (0,00)
After hours
Closed: 2 Okt., 16:03:54 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DGX...
Open
USD 230,58
High
USD 233,48
Low
USD 228,83
Mkt. cap
25,75 mjd
Avg. vol.
1,08 m
Volume
1,10 m
Dividend
1,47%
Quarterly dividend
USD 0,86
Ex-dividend date
06 Okt. 2026
P/E ratio
24,80
52-wk high
USD 248,84
52-wk low
USD 171,18
EPS
USD 9,41
Beta
0,54
Shares outstanding
110,37 m
No. of employees
52 k
Open
USD 230,58
High
USD 233,48
Low
USD 228,83
Mkt. cap
25,75 mjd
Avg. vol.
1,08 m
Volume
1,10 m
Dividend
1,47%
Quarterly dividend
USD 0,86
Ex-dividend date
06 Okt. 2026
P/E ratio
24,80
52-wk high
USD 248,84
52-wk low
USD 171,18
EPS
USD 9,41
Beta
0,54
Shares outstanding
110,37 m
No. of employees
52 k
News stories
From web sources and news partners
Profile
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing. Wikipedia
About Quest Diagnostics Inc
CEOJames E. Davis
Employees51,5 k
Founded1967
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 11 analysts giving stock ratings to DGX in the past 3 months
Buy
Buy
7
Hold
4
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for DGX in the last 3 months.
Highest
Current USD 233,33
USD 265,00 (+13,57%)
Average
USD 255,00 (+9,29%)
Lowest
USD 245,00 (+5,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Maintained
USD 250,00
+7,1%
09/23/2026
David S Macdonald
Truist Financial
Hold
Reiterated
USD 260,00
+11,4%
09/22/2026
Kevin Caliendo
UBS
Hold
Maintained
USD 245,00
+5%
09/08/2026
Erin Wright
Morgan Stanley
Buy
Maintained
USD 260,00
+11,4%
08/19/2026
David Toung
Argus Research
Buy
Maintained
USD 260,00
+11,4%
07/28/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 260,00
+11,4%
07/28/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
USD 250,00
+7,1%
07/28/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
USD 265,00
+13,6%
07/24/2026
Eric Coldwell
Robert W. Baird
Hold
Maintained
USD 255,00
+9,3%
07/24/2026
Tycho Peterson
Jefferies
Buy
Reiterated
USD 245,00
+5%
07/23/2026
Jared Haase
William Blair
Buy
Maintained
-
-
07/23/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
06/15/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
USD 210,00
-10%
04/20/2026
Patrick B Donnelly
Citi
Hold
Maintained
USD 215,00
-7,9%
02/11/2026
Last report
23 Jul. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 3,12 / USD 2,82
+10,51%beat
Revenue / Est. (USD)
3,04 mjd / 2,97 mjd
+2,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,82 mjd
2,81 mjd
2,90 mjd
3,04 mjd
Cost of goods sold
1,86 mjd
1,89 mjd
1,95 mjd
2,02 mjd
Cost of revenue
1,86 mjd
1,89 mjd
1,95 mjd
2,02 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
491,00 m
486,00 m
498,00 m
526,00 m
Operating expense
531,00 m
523,00 m
533,00 m
564,00 m
Total operating expenses
2,40 mjd
2,41 mjd
2,48 mjd
2,58 mjd
Operating income
420,00 m
392,00 m
411,00 m
464,00 m
Other non operating income
8,00 m
9,00 m
-2,00 m
16,00 m
EBT including unusual items
336,00 m
337,00 m
338,00 m
422,00 m
EBT excluding unusual items
370,00 m
344,00 m
350,00 m
427,00 m
Income tax expense
77,00 m
81,00 m
74,00 m
88,00 m
Effective tax rate
22,92%
24,04%
21,89%
20,85%
Other operating expenses
1,00 m
-
-2,00 m
-
Net income
245,00 m
245,00 m
252,00 m
320,00 m
Net profit margin
8,70%
8,73%
8,70%
10,52%
Earnings per share
2,60
2,42
2,50
3,12
Interest and investment income
3,00 m
3,00 m
2,00 m
5,00 m
Interest expense
-69,00 m
-67,00 m
-65,00 m
-68,00 m
Net interest expenses
-66,00 m
-64,00 m
-63,00 m
-63,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
562,00 m
537,00 m
558,00 m
610,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme